intravenous therapies. The Cambridge, Mass., company has already started promoting the drug in advance of approval. Incivek and Merck & Co's Victrelis, which was approved earlier this month, are the first new treatments for the liver disease to be...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to FDA clears Vertex's hepatitis C drug Incivek
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account